A 10-Year Community-Based Study of Leucine-Rich Repeat Kinase 2 G2385R Carriers' Conversion to Parkinson's Disease.
Pei WangJing PanQi LuoJie ChenHuidong TangSheng-Di ChenJianfang MaPublished in: Movement disorders : official journal of the Movement Disorder Society (2022)
We confirmed an increased conversion of PD in leucine-rich repeat kinase 2 G2385R carriers during a 10-year follow-up. © 2022 International Parkinson and Movement Disorder Society.
Keyphrases